LA Financiere DE L Echiquier lowered its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 16.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 25,000 shares of the medical research company’s stock after selling 5,000 shares during the quarter. Thermo Fisher Scientific accounts for about 3.3% of LA Financiere DE L Echiquier’s holdings, making the stock its 14th biggest position. LA Financiere DE L Echiquier’s holdings in Thermo Fisher Scientific were worth $4,730,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in TMO. Winslow Capital Management LLC raised its stake in shares of Thermo Fisher Scientific by 25.0% during the 1st quarter. Winslow Capital Management LLC now owns 2,198,174 shares of the medical research company’s stock worth $337,639,000 after buying an additional 439,847 shares during the last quarter. Rosenblum Silverman Sutton S F Inc. CA raised its stake in Thermo Fisher Scientific by 1.6% in the 1st quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 43,813 shares of the medical research company’s stock valued at $6,730,000 after purchasing an additional 669 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Thermo Fisher Scientific by 2.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,835,460 shares of the medical research company’s stock valued at $435,527,000 after purchasing an additional 57,480 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec raised its stake in Thermo Fisher Scientific by 4.3% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 901,182 shares of the medical research company’s stock valued at $138,572,000 after purchasing an additional 37,400 shares during the last quarter. Finally, Johnson Financial Group Inc. raised its stake in Thermo Fisher Scientific by 2.5% in the 1st quarter. Johnson Financial Group Inc. now owns 1,619 shares of the medical research company’s stock valued at $249,000 after purchasing an additional 39 shares during the last quarter. 86.16% of the stock is owned by institutional investors and hedge funds.

Thermo Fisher Scientific Inc. (NYSE:TMO) traded up $1.76 on Friday, reaching $185.63. The company’s stock had a trading volume of 1,550,000 shares, compared to its average volume of 1,561,300. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The stock has a market cap of $73,731.02, a PE ratio of 20.20, a price-to-earnings-growth ratio of 1.68 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 52 week low of $139.88 and a 52 week high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a return on equity of 9.09% and a net margin of 10.44%. The firm’s revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.03 EPS. equities research analysts predict that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is currently 10.19%.

In other news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the completion of the sale, the chief executive officer now owns 252,577 shares in the company, valued at approximately $47,582,981.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.49% of the stock is currently owned by insiders.

Several brokerages recently weighed in on TMO. Jefferies Group reissued a “hold” rating and issued a $195.00 target price on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research note on Thursday, September 7th. Leerink Swann reissued an “outperform” rating and issued a $200.00 target price (down previously from $216.00) on shares of Thermo Fisher Scientific in a research note on Monday. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, Morgan Stanley reissued an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research note on Wednesday, September 6th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $205.21.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/08/thermo-fisher-scientific-inc-tmo-holdings-reduced-by-la-financiere-de-l-echiquier.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.